AMAC member gives video testimony
AMAC Action President Bob Carlstrom was at the Rose Garden with other guests yesterday as President Trump made a significant announcement regarding the price of insulin. Starting in 2021, many Medicare Part D plans and Medicare Advantage plans have applied to offer lower out-of-pocket insulin costs for seniors. Participating enhanced Part D plans will provide many seniors with Medicare access to a broad set of insulins at a maximum copay of just $35 for a month’s supply of each insulin. A video statement from AMAC member Alan Arnfield describing his experience with paying for expensive insulin was played during the announcement.
Many AMAC members are prescribed insulin to help manage their diabetes, and they tell us of the hard choices they have to make in order to purchase their insulin, like rationing it or going without some of the basic necessities of life to afford it. This reduced price will have a significant effect on both the health and quality of life for seniors throughout the country.
President Trump and his administration have worked tirelessly to provide quality, affordable healthcare for our America’s seniors. Last year, the President signed an executive order to promote quality care for our seniors and improve the fiscal sustainability of Medicare. Under President Trump, average basic premiums for Medicare Part D plans are their lowest in 7 years. Part D premiums have fallen by 13.5 percent since 2017, saving beneficiaries $1.9 billion in premium costs.
Andrew Mangione is Senior Vice President for AMAC’s advocacy affiliate, AMAC Action. He leads AMAC’s grassroots efforts, represents AMAC’s membership in Washington, D.C., and helps chart the association’s policy course. He also serves as a national spokesperson.